Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-12-15 Ruffo Frank Chief Financial Officer Exercise or conversion · Restricted Stock Units −1,300 9,100
2017-12-15 Powala Christopher Chief Operating Officer Exercise or conversion +1,300 132,865
2017-12-15 Powala Christopher Chief Operating Officer Shares withheld for taxes −395 $24.23 $10K 132,470
2017-12-15 Powala Christopher Chief Operating Officer Exercise or conversion · Restricted Stock Units −1,300 9,100
2017-12-15 Ali-Jackson Kamil Chief Legal Officer Exercise or conversion +1,733 78,438
2017-12-15 Ali-Jackson Kamil Chief Legal Officer Shares withheld for taxes −527 $24.23 $13K 77,911
2017-12-15 Ali-Jackson Kamil Chief Legal Officer Exercise or conversion · Restricted Stock Units −1,733 12,133
2017-12-15 Shanler Stuart Chief Scientific Officer Exercise or conversion +1,300 263,178
2017-12-15 Shanler Stuart Chief Scientific Officer Shares withheld for taxes −395 $24.23 $10K 262,783
2017-12-15 Shanler Stuart Chief Scientific Officer Exercise or conversion · Restricted Stock Units −1,300 9,100
2017-08-16 SCHIFF ANDREW N Director Purchase +108,601 $23.02 $2.5M 634,455
2017-08-09 SCHIFF ANDREW N Director Grant or award · Stock Option (right to buy) +16,000 16,000
2017-06-15 Bierly Rick Director Grant or award · Stock Option (right to buy) +8,000 8,000
2017-06-15 Humphries William D. Director Grant or award · Stock Option (right to buy) +8,000 8,000
2017-06-15 Powell Andrew Kenneth William Director Grant or award · Stock Option (right to buy) +8,000 8,000
2017-06-15 Molineaux Christopher P. Director Grant or award · Stock Option (right to buy) +8,000 8,000
2017-06-15 Mehra Anand Director Grant or award · Stock Option (right to buy) +8,000 8,000
2017-03-17 Molineaux Christopher P. Director Exercise or conversion +6,702 $0.41 $3K 6,702
2017-03-17 Molineaux Christopher P. Director Exercise or conversion +592 $1.52 $900 7,294
2017-03-17 Molineaux Christopher P. Director Exercise or conversion +311 $0.72 $224 7,605

Page 49 of 57 · 1,130 trades